NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.

Kushal Kadakia is a student at Harvard Medical School with a background in delivery-system reform. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. K.T. Kadakia and H.M. Krumholz. Designing Cures 2.0 — From Corridors to Cornerstones. N Engl J Med 2022;386:1677-1679. J. Concato and J. Corrigan-Curay. Real-World Evidence — Where Are We Now? N Engl J Med 2022;386:1680-1682.